摘要
目的:观察噻肟单酰胺菌素治疗尿路感染的临床疗效和安全性.方法:选择尿路感染病例114例,随机分成2组;治疗组60例(男11例,女49例,年龄(43±15岁),其中复杂性尿路感染病人24例.对照组54例(男12例、女42例,年龄(41±15岁),其中复杂性尿路感染13例.治疗组给予噻肟单酰胺菌素1.2-2.0g加入生理盐水中250ml中静滴,一日2次,疗程7-14d.对照组给予丁胺卡那霉素0.2g加入生理盐水250ml中静滴,一日1次,疗程7-14d.结果:治疗组总有效率63.3%,对照组总有效率64.8%,治疗组疗效明显优于对照组(P<0.05).结论:噻肟单酰胺菌素治疗尿路感染,特别是上尿路感染疗效好,安全性高.
To observe the efllciency and sattty of primbactin for urineq tract infections, 114 casses of urinarytract infection were randomly divided into two groups. 60 patients (M 11, F49, age 43 ±15) including thecomplex 24 casses of complex urinary tract infection receved primbactin 1.0~2.0 in 250ml of 0.9% sodiumchloride injectons, iv,drip, Bid. for 7~14d; The other 54 patients as control (M 12, F 42, ages 41 ± 15) including17 casses of complex urineq tract infection received amikacin 0.2 in 250ml of 0.9% sodium chloride injections,iv, drip, Bid, for 7~14d. The total effective rate was 83.3% in the therapy group and 64.8% in the control group,with significant difference (P<0.05)- Theretbre, primbactin is an effective and safe antibioticl in treating urinarytract infection, especially upper urinary tract infection.
出处
《黑龙江医药科学》
1998年第6期1-2,共2页
Heilongjiang Medicine and Pharmacy